Common use of Associate Partners Clause in Contracts

Associate Partners. As noted earlier, CompBioMed has been very successful in attracting new collaborators, as represented by the current 40 Associate Partners, and their number is growing rapidly. Associate Partners are encouraged to participate in CompBioMed meetings and events throughout the project, which gives them the opportunity to join our full network of partners and help steer the future of computational biomedicine through their influence on the actions of our Centre. Associate Partners also get complete access to the training provided by CompBioMed. The list of benefits for Associate Partners includes: ● access to and provision of project resources including HPC facilities ● access to and provision of software ● access to and provision of training materials ● invitations to project meetings ● invitations to our workshops ● invitations to our training events ● listing as an associate partner on the CompBioMed website ● participation in our Innovation Exchange Programme ● participation in Incubator Coordination ● possible participation in our Innovation Advisory Board ● listing of software services on the CompBioMed Software Hub CompBioMed Core Partners actively collaborate with companies/institutions outside the Core Partnership, often this collaboration will lead to them joining as an Associate Partner. Once such a company/institution has been identified, the project coordinator will send them an invitation email which outlines the benefits and opportunities that we offer to such entities [the list above]. We do not ask for any paperwork to be signed, unless they were to be involved in a meeting during which we would discuss confidential work from the partners. Once an agreement has been reached, we will add them to the Associate Partner page (▇▇▇.▇▇▇▇▇▇▇▇▇▇.▇▇/▇▇▇▇▇▇▇▇▇-▇▇▇▇▇▇▇▇), we announce them to the consortium (either through a dedicated email or in the monthly e-newsletter) and we add the inclusion of them on Twitter, the major contact is also added to our “all” and “associate” mailing lists. This way, we hope to inform all the major user groups within our consortium, and we keep the Associate Partner updated on the current work within the consortium, thereby encouraging further collaborations. Our Associate Partners include institutions from industry, academia, medical hospitals and HPC Centres, and they benefit from their association with CompBioMed by either being engaged with a Core or another Associate Partner. Further, they may use CompBioMed resources or allow CompBioMed members to employ their resources, where these include HPC and HPDA resources or simply exploiting CompBioMed’s growing information hub. The list of Associate Partners includes the following partners from Industry; Avicenna Alliance, GSK, DNAnexus, Alces Software, Electric Ant Lab BV, Norton Straw Consultants, Pozlab (Poznan), Qatar Robotic Surgery Centre (Hamad Medical Corporation), Microsoft, DiaVita (Life Science), Dassault Systemes, Lightox, InSilicoTrials, ANSYS, Medtronic, Pie Medical Imaging, and AstraZeneca.

Associate Partners. As noted earlier, CompBioMed has been very successful in attracting new collaborators, as represented by the current 40 33 Associate Partners, and their number is growing rapidly. Associate Partners are encouraged to participate in CompBioMed meetings and events throughout the project, which gives them the opportunity to join our full network of partners and help steer the future of computational biomedicine through their influence on the actions of our Centre. Associate Partners also get complete access to the training provided by CompBioMed. The list of benefits for Associate Partners includes: ● access to and provision of project resources including HPC facilities ● access to and provision of software ● access to and provision of training materials ● invitations to project meetings ● invitations to our workshops ● invitations to our training events ● listing as an associate partner on the CompBioMed website ● participation in our Innovation Exchange Programme ● participation in Incubator Coordination ● possible participation in our Innovation Advisory Board ● listing of software services on the CompBioMed Software Hub CompBioMed Core There is no formal process involving paperwork required to allow Associate Partners actively collaborate with companies/institutions outside the Core Partnershipto join; however, often this collaboration will lead to them joining as we may require an Associate Partner. Once such a company/institution has been identified, the project coordinator will send them an invitation email which outlines the benefits and opportunities that we offer to such entities [the list above]. We do not ask for any paperwork NDA to be signed, unless they were to be involved in a meeting during which we would discuss confidential work from signed for the partners. Once an agreement has been reached, we will add them to the Associate Partner page (▇▇▇.▇▇▇▇▇▇▇▇▇▇.▇▇/▇▇▇▇▇▇▇▇▇-▇▇▇▇▇▇▇▇), we announce them to the consortium (either through a dedicated email or in the monthly e-newsletter) and we add the inclusion purposes of them on Twitter, the major contact some CompBioMed meetings where IP is also added to our “all” and “associate” mailing lists. This way, we hope to inform all the major user groups within our consortium, and we keep the Associate Partner updated on the current work within the consortium, thereby encouraging further collaborationsinvolved. Our Associate Partners include institutions from industry, academia, medical hospitals and HPC Centres, and they benefit from their association with CompBioMed by either being engaged with a Core or another Associate Partner. Further, they may use CompBioMed resources or allow CompBioMed members to employ their resources, where these include HPC and HPDA resources or simply exploiting CompBioMed’s growing information hub. The list of current Associated Partners is presented via the ▇▇▇ webpage ▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇▇▇.▇▇/associate-partners/ The list of Associate Partners currently stands at 33, and includes the following partners from Industry; Avicenna Alliance, Convergence Pharmaceuticals, GSK, DNAnexus, Oxford Biomedical Research Centre, Alces Software, Electric Ant Lab BV, Norton Straw Consultants, Pozlab (Poznan), Qatar Robotic Surgery Centre (Hamad Medical Corporation), Microsoft, DiaVita (Life Science), Dassault SystemesSystems, Lightox, InSilicoTrials, ANSYS, Lightox and Medtronic, Pie Medical Imaging, and AstraZeneca.